What does agomelatine bring to treatment of depression?an up-to-date review
Yazarlar (6)
Cem Cerit
Kocaeli Üniversitesi, Türkiye
Kocaeli Üniversitesi, Türkiye
Irem Yaluǧ
Kocaeli Üniversitesi, Türkiye
Kocaeli Üniversitesi, Türkiye
Doç. Dr. Esma AKPINAR ASLAN Haydarpaşa Numune Eǧitim ve Araştirma Hastanesi Psikiyatri Kliniǧi, Türkiye
Anil Talas
Haydarpaşa Numune Eǧitim ve Araştirma Hastanesi Psikiyatri Kliniǧi, Türkiye
Haydarpaşa Numune Eǧitim ve Araştirma Hastanesi Psikiyatri Kliniǧi, Türkiye
Prof. Dr. Ali Evren Tufan Bolu Abant İzzet Baysal Üniversitesi, Türkiye
Eylem Özten
Üsküdar Üniversitesi, Türkiye
Üsküdar Üniversitesi, Türkiye
| Makale Türü | Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri) (SCOPUS dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale) | ||
| Dergi Adı | Yeni Symposium | ||
| Dergi ISSN | 1300-8773 | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2013 |
| Cilt / Sayı / Sayfa | 51 / 3 / 123–131 | DOI | – |
| UAK Araştırma Alanları |
Sağlık Bilimleri
|
||
| Özet |
| In this article literature related to the promises of agomelatine, an antidepressant with melatonergic MT-1 and MT- 2 receptor agonism and seratoninergic 5-HT2c receptor antagonism in the context of depression treatment is reviewed. Although the results of studies on the efficacy of agomelatine are contrary, it can be stressed that the efficacy of agomelatine should be at least similar to widely used antidepressants. Furthermore the favorable effect of agomelatine on sleep and the early onset of efficacy should contribute to the outcome of therapy. The favorable effect of agomelatine on the circadian rhythm which has influence on substantial biological systems like sleepwake cycle, endocrine hormone secretion and body temperature appears to be interesting. Somnolence should be noted as a more frequent adverse event of agomelatine than other antidepressants. Furthermore the absence of weight gain and sexual adverse events should influence the adherence to therapy. Liver enzyme elevations can emerge during agomelatine therapy. Abrupt discontinuation of agomelatine does not appear to bring about evident discontinuation symptoms. |
| Anahtar Kelimeler |
| Agomelatine | Depression | Melatonin |
